ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

IF 6.6 1区医学 Q1 GENETICS & HEREDITY

Genetics in Medicine Pub Date : 2025-06-23 DOI:10.1016/j.gim.2025.101454

Kristy Lee , Noura S. Abul-Husn , Laura M. Amendola , Kyle B. Brothers , Wendy K. Chung , Michael H. Gollob , Adam S. Gordon , Steven M. Harrison , Ray E. Hershberger , Marilyn Li , Deborah Ondrasik , C. Sue Richards , Andrew Stergachis , Douglas R. Stewart , Christa Lese Martin , David T. Miller , ACMG Secondary Findings Working Group

引用次数: 0

查看原文本刊更多论文

ACMG SF v3.3临床外显子组和基因组测序次要发现报告清单：美国医学遗传学和基因组学学院（ACMG）政策声明

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Genetics in Medicine 医学-遗传学

CiteScore

15.20

自引率

6.80%

发文量

857

审稿时长

1.3 weeks

期刊介绍： Genetics in Medicine (GIM) is the official journal of the American College of Medical Genetics and Genomics. The journal''s mission is to enhance the knowledge, understanding, and practice of medical genetics and genomics through publications in clinical and laboratory genetics and genomics, including ethical, legal, and social issues as well as public health. GIM encourages research that combats racism, includes diverse populations and is written by authors from diverse and underrepresented backgrounds.